Press release
China Cancer Biomarker Market Growth, Size, Share, Industry Report and Forecast 2019-2025
China cancer biomarkers market is growing at a CAGR of around 11.8% during the forecast period. China has a strong market for cancer biomarkers due to huge government investments in R&D and Life Science projects, prevalence of cancer and increasing adoption of personalized medicine. All these factors are contributing to the growth of China cancer biomarker market. Biomarker- targeted therapies approval in China is led by the development of various oncology biomarkers, such as EGFR, RAS, HER2, BRCA. There efficacy in the diagnosis of treatment of cancer has led the researchers and biopharmaceuticals to focus personalized medicine on biomarkers for cancer. In addition, the Government of China is investing heavily in life science research spurring the development and adoption of biomarkers for personalized medicine. The 13th Five-year Plan (2015-2020) by the Chinese government will further fuel the growth of the market as the plan focusses on the development of innovative medicines, with biomedicine being identified as a key priority.
To Request a Sample of our Report on China Cancer Biomarker Market: https://www.omrglobal.com/request-sample/china-cancer-biomarker-market
In October 2017, a US based company called Gentris, working in the field of genomic biomarkers in clinical studies, signed a Memorandum of Understanding to form a biomarker collaboration with the Shanghai Institutes of Preventative Medicine. This partnership is done with the objective to discover new biomarkers. It will result in the development of translational research and epidemiological projects based on pharmacogenomics. In addition, it will provide clinical sample banking, which are services provided by the Gentris to the clients in the US for clinical trials and genomic biomarker programs. This is augmenting the growth of the china cancer biomarker market.
In 2015, there were nearly 4.3 million new cancer patients in China including 730,000 cases of lung cancer, which accounted for 36% of the total cases. Early diagnosis and risk assessment are essential for Lung cancer diagnosis. Many factors involved in those processes could serve as biomarkers for early diagnosis or early screening tools for lung cancer which has augmented the growth of lung cancer. In January 2018, China's FDA approved Amoy Diagnostics' SuperARMS EGFR mutation analysis test as a companion diagnostic for EGFR TKI-based non-small cell lung cancer drugs.
(Get 15% Discount on Buying this Report)
A full Report of China Cancer Biomarker Market is Available @ https://www.omrglobal.com/industry-reports/china-cancer-biomarker-market
China Cancer Biomarker Market Segmentation
By Biomarker Type
· Genetic Biomarker
· Protein Biomarker
By Cancer Type
· Lung Cancer
· Prostate Cancer
· Breast Cancer
· Colorectal Cancer
· Cervical Cancer
· Other
By Applications
· Drug Discovery and Development
· Diagnosis
· Risk Assessment
· Prognostics
By Profiling Technology
· Omics Technology
· Immunoassays
· Cytogenetics
· Bioinformatics
Company Profiles
· Abbott Laboratories Inc.
· Astellas Pharma Inc.
· Becton, Dickson and Co.
· Bio-Rad Laboratories, Inc.
· Danaher Corp.
· F. Hoffmann-La Roche Ltd.
· Merck and Co., Inc.
· Novartis AG
· Pfizer Inc.
· QIAGEN GmbH
· Thermo Fisher Scientific Inc.
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
To Request a Sample of our Report on China Cancer Biomarker Market: https://www.omrglobal.com/request-sample/china-cancer-biomarker-market
In October 2017, a US based company called Gentris, working in the field of genomic biomarkers in clinical studies, signed a Memorandum of Understanding to form a biomarker collaboration with the Shanghai Institutes of Preventative Medicine. This partnership is done with the objective to discover new biomarkers. It will result in the development of translational research and epidemiological projects based on pharmacogenomics. In addition, it will provide clinical sample banking, which are services provided by the Gentris to the clients in the US for clinical trials and genomic biomarker programs. This is augmenting the growth of the china cancer biomarker market.
In 2015, there were nearly 4.3 million new cancer patients in China including 730,000 cases of lung cancer, which accounted for 36% of the total cases. Early diagnosis and risk assessment are essential for Lung cancer diagnosis. Many factors involved in those processes could serve as biomarkers for early diagnosis or early screening tools for lung cancer which has augmented the growth of lung cancer. In January 2018, China's FDA approved Amoy Diagnostics' SuperARMS EGFR mutation analysis test as a companion diagnostic for EGFR TKI-based non-small cell lung cancer drugs.
(Get 15% Discount on Buying this Report)
A full Report of China Cancer Biomarker Market is Available @ https://www.omrglobal.com/industry-reports/china-cancer-biomarker-market
China Cancer Biomarker Market Segmentation
By Biomarker Type
· Genetic Biomarker
· Protein Biomarker
By Cancer Type
· Lung Cancer
· Prostate Cancer
· Breast Cancer
· Colorectal Cancer
· Cervical Cancer
· Other
By Applications
· Drug Discovery and Development
· Diagnosis
· Risk Assessment
· Prognostics
By Profiling Technology
· Omics Technology
· Immunoassays
· Cytogenetics
· Bioinformatics
Company Profiles
· Abbott Laboratories Inc.
· Astellas Pharma Inc.
· Becton, Dickson and Co.
· Bio-Rad Laboratories, Inc.
· Danaher Corp.
· F. Hoffmann-La Roche Ltd.
· Merck and Co., Inc.
· Novartis AG
· Pfizer Inc.
· QIAGEN GmbH
· Thermo Fisher Scientific Inc.
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
